Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Project ALS and Amylyx Enter Collaboration to Test AMX0035
Friday, September 08, 2017Project ALS and Amylyx Pharmaceuticals today announced a collaboration to undertake preclinical studies with Amylyxs oral compound AMX to advance the understanding of the compounds neurobiological effects The studies to be conducted at the Project AL...
Bristol-Myers Squibb Completes Acquisition of IFM Therapeutics
Friday, September 08, 2017BristolMyers Squibb Company announced that it has completed the previously announced planned acquisition of IFM Therapeutics The transaction includes full rights to IFMs preclinical STING stimulator of interferon genes and NLRP agonist programs fo...
Alcami to Establish Active Pharmaceutical Ingredient Center of Excellence in Germantown, Wisconsin
Thursday, September 07, 2017Alcami Corporation a leading provider of custom development and manufacturing services for the pharmaceutical and biotechnology industries today announces the formation of a Center of Excellence at its worldclass active pharmaceutical ingredient API...
Immune Therapeutics, Inc. Announces Exclusive Agreement For Sale Of Lodonal In Kenya
Thursday, September 07, 2017Immune Therapeutics Inc a specialty pharmaceutical company focused on developing and commercializing Lodonal its patented affordable nontoxic therapy for the management of cancer HIV autoimmune diseases and other inflammatory conditions today announc...
Ligand Announces Top-Line Results from Phase 2 Study of LGD-6972 in Patients with Type 2 Diabetes
Wednesday, September 06, 2017Ligand Pharmaceuticals Incorporated announced positive topline results from a Phase clinical study evaluating the efficacy and safety of LGD as an adjunct to diet and exercise in subjects with type diabetes mellitus TDM inadequately controlled on m...
MEI Pharma Announces Exclusive License Agreement with Presage Biosciences
Wednesday, September 06, 2017MEI Pharma Inc an oncology company focused on the clinical development of novel therapies for cancer today announced that it has entered into a license agreement with Presage Biosciences Inc for voruciclib a clinicalstage oral and selective cyclindep...
Sanofi Receives Tentative FDA Approval of Admelog® (insulin lispro injection) 100 Units/mL
Monday, September 04, 2017Sanofi announced that the US Food and Drug Administration FDA granted tentative approval for Admelog insulin lispro injection UnitsmL a rapidacting human insulin analog Admelog is indicated to improve glycemic control in adults and children with dia...
3SBio Accelerates Expansion of its Global Biologics Platform by Acquiring the Canadian Biomanufacturing Business of Therapure
Monday, September 04, 2017SBio Inc a leading Chinese biopharmaceutical company is pleased to announce today that it has entered into a Shareholder Agreement with CPE Funds pursuant to which a Joint Venture the JV shall be established The Group and CPE Funds seek to position t...
Daiichi Sankyo Terminates Development and Commercialization Agreement with Charleston Laboratories
Friday, September 01, 2017Daiichi Sankyo Co Ltd and its US subsidiary Daiichi Sankyo Inc announced that the company has elected to terminate its development and commercialization agreement with Charleston Laboratories forgoing further involvement with the development and com...
RegeneRx Completes License Expansion for RGN-137 in Europe, S. Korea, Japan, Canada and Australia
Friday, September 01, 2017RegeneRx Biopharmaceuticals Inc a clinicalstage drug development company focused on tissue protection repair and regeneration today announced that it has completed a license expansion agreement with GtreeBNT for the rights to RGN RegeneRxs topical ge...
